TradingView
RocketTickers
Dec 23, 2019 5:56 PM
FDA Approves Intra-Cellular Therapies’ Novel Antipsychotic, CAPL
Long
NASDAQ:ITCI
1D
Intra-Cellular Therapies Inc.
NASDAQ
Description
⋅
Dec 23, 2019 5:56 PM
ITCI: Intra-Cellular Therapies Inc.
2019-12-23 06:59:10
FDA Approves Intra-Cellular Therapies’ Novel Antipsychotic, CAPLYTA® (lumateperone) for the Treatment of Schizophrenia in Adults
Beyond Technical Analysis
More